Continuum Advisory’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Continuum Advisory’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-135	Closed	-$23K	–	782
2025 Q1	$23K	Hold	135	–	–	﹤0.01%	830
2024 Q4	$22.4K	Hold	135	–	–	﹤0.01%	820
2024 Q3	$23K	Hold	135	–	–	﹤0.01%	812
2024 Q2	$20.8K	Hold	135	–	–	﹤0.01%	783
2024 Q1	$20.1K	Buy	+135	New	+$20.6K	﹤0.01%	772
2022 Q1	–	Sell	-4,799	Closed	-$777K	–	383
2021 Q4	$777K	Buy	4,799 +571	+14%	+$92.3K	0.17%	132
2021 Q3	$702K	Buy	4,228 +568	+16%	+$97K	0.19%	122
2021 Q2	$632K	Buy	3,660 +246	+7%	+$40.6K	0.2%	115
2021 Q1	$555K	Buy	+3,414	New	+$585K	0.23%	91
2019 Q3	–	Sell	-2,067	Closed	-$292K	–	132
2019 Q2	$292K	Sell	2,067 -265	-11%	-$36.6K	0.2%	95
2019 Q1	$352K	Sell	2,332 -100	-4%	-$14.4K	0.26%	91
2018 Q4	$302K	Sell	2,432 -110	-4%	-$15K	0.22%	108
2018 Q3	$400K	Hold	2,542	–	–	0.27%	93
2018 Q2	$356K	Sell	2,542 -100	-4%	-$13.7K	0.26%	94
2018 Q1	$351K	Buy	+2,642	New	+$361K	0.29%	87

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Continuum Advisory's FBT Position: Q2 2025 in Review

Continuum Advisory sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2025, closing a stake of 135 shares — an estimated $23K sold.

Continuum Advisory first reported a position in FBT in Q1 2018 and held it in 15 quarters. The position peaked at $777K in Q4 2021. 250 funds tracked by Wall St. Rank hold FBT as of Q2 2025.

Continuum Advisory reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2025 after selling out during the quarter.
Continuum Advisory sold 135 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2025, an estimated $23K.
Continuum Advisory first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2018 and held it in 15 quarters.
Continuum Advisory's First Trust NYSE Arca Biotechnology Index Fund position peaked at $777K in Q4 2021.
250 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.